Followers | 34 |
Posts | 1933 |
Boards Moderated | 1 |
Alias Born | 04/02/2007 |
Thursday, July 02, 2009 4:38:55 PM
On April 24, 2009 the Company received a letter from Nasdaq confirming that it was not in compliance with Listing Rule 5605 and providing the Company a cure period to regain compliance through October 5, 2009.
During the cure period, the Company's common shares will continue to trade on Nasdaq, subject to the Company's continued compliance with other Nasdaq listing requirements. The Company has begun the process of identifying a third Audit Committee member and expects to regain compliance with Nasdaq's audit committee composition requirements within the cure period.
A Prosperity Blessing.
May you be blessed with an amazingly abundant day today!
May the clouds break and the heavens pour down upon you more joy, more love, more laughter and more money than you could have ever dreamed of.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM